Zdrowie i gospodarka · 13/12/2019

FDA Releases Draft Guidance for Pediatric Studies of Molecularly Targeted Oncology Drugs

The Food and Drug Administration (FDA) has published a draft guidance outlining the requirements for pediatric studies of certain molecularly targeted oncology drugs, which are expected to be submitted to the FDA on or after August 18, 2020.